You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Article info

Article menu

Download PDFPDF

XML
Research Article
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Authors

  • Fan Luo State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Min Luo State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Qi-Xiang Rong State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Hong Zhang State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Zhen Chen State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Fang Wang State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Hong-Yun Zhao State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Li-Wu Fu State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer InstituteSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles

Citation

Luo F, Luo M, Rong Q, et al
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2019;7:245. doi: 10.1186/s40425-019-0733-7
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.